-- 
Evotec Reports Second Multi-Target Collaboration With UCB

-- B y   M a r i a j o s e   V e r a
-- 
2011-10-05T05:33:59Z

-- http://www.bloomberg.com/news/2011-10-05/evotec-reports-second-multi-target-collaboration-with-ucb.html
Evotec AG (EVT)  entered into a second
multi-year, multi-target drug discovery cooperation with  UCB SA (UCB) 
in the field of immunology. Evotec will identfy small molecules
against a selected number of targets.  Evotec will receive research funding based on the resource
allocated over the projects and will be further rewarded on
achieving the goals with early stage discovery, preclinical and
clinical milestones.Â Evotec will also receive royalties based on
net sales of any approved drugs.  To contact the editor responsible for this story:
Mariajose Vera at 
 mvera1@bloomberg.net  